TMC Life Sciences Berhad (KLSE:TMCLIFE)
Malaysia
· Delayed Price · Currency is MYR 0.455
-0.005 (-1.09%)
At close: Feb 21, 2025
TMC Life Sciences Berhad Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Operating Revenue | 322.59 | 346.42 | 311.44 | 243.77 | 201.02 | 184.09 | Upgrade
|
| Other Revenue | - | - | 0.11 | - | - | - | Upgrade
|
| Revenue | 322.59 | 346.42 | 311.56 | 243.77 | 201.02 | 184.09 | Upgrade
|
| Revenue Growth (YoY) | -8.50% | 11.19% | 27.81% | 21.27% | 9.20% | -5.59% | Upgrade
|
| Cost of Revenue | 214.13 | 208.4 | 185.5 | 155.89 | 131.52 | 126.05 | Upgrade
|
| Gross Profit | 108.46 | 138.02 | 126.06 | 87.88 | 69.5 | 58.04 | Upgrade
|
| Other Operating Expenses | 56.93 | 52.75 | 53 | 39.94 | 30.65 | 28.4 | Upgrade
|
| Operating Expenses | 87.25 | 80.66 | 79.01 | 55.79 | 43.67 | 40.33 | Upgrade
|
| Operating Income | 21.21 | 57.36 | 47.05 | 32.09 | 25.84 | 17.7 | Upgrade
|
| Interest Expense | -9.94 | -10.25 | -9.4 | -2.09 | -0.44 | -0.39 | Upgrade
|
| Interest & Investment Income | 5.46 | 5.47 | 3.25 | 2 | 2.19 | 4.15 | Upgrade
|
| EBT Excluding Unusual Items | 16.72 | 52.58 | 40.89 | 32 | 27.58 | 21.47 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.36 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.06 | 0.01 | Upgrade
|
| Other Unusual Items | 0.04 | 0.04 | - | 0.18 | 0.03 | 0.27 | Upgrade
|
| Pretax Income | 16.76 | 52.62 | 40.89 | 32.18 | 27.67 | 22.1 | Upgrade
|
| Income Tax Expense | 3.79 | 11.97 | 1.63 | -9.21 | 7.42 | 6.17 | Upgrade
|
| Net Income | 12.97 | 40.65 | 39.26 | 41.39 | 20.25 | 15.93 | Upgrade
|
| Net Income to Common | 12.97 | 40.65 | 39.26 | 41.39 | 20.25 | 15.93 | Upgrade
|
| Net Income Growth | -77.32% | 3.54% | -5.15% | 104.35% | 27.14% | -23.85% | Upgrade
|
| Shares Outstanding (Basic) | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 | Upgrade
|
| Shares Outstanding (Diluted) | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 | 1,742 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | - | 0.24% | Upgrade
|
| EPS (Basic) | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
| EPS Growth | -77.44% | 3.56% | -5.31% | 104.85% | 27.18% | -24.00% | Upgrade
|
| Free Cash Flow | -1.62 | 49.41 | 22.61 | -32.04 | -80.18 | -146.08 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.03 | 0.01 | -0.02 | -0.05 | -0.08 | Upgrade
|
| Dividend Per Share | 0.005 | 0.005 | 0.004 | 0.003 | 0.002 | 0.002 | Upgrade
|
| Dividend Growth | 16.65% | 16.65% | 51.97% | 24.74% | 9.98% | 0.05% | Upgrade
|
| Gross Margin | 33.62% | 39.84% | 40.46% | 36.05% | 34.57% | 31.53% | Upgrade
|
| Operating Margin | 6.57% | 16.56% | 15.10% | 13.16% | 12.85% | 9.62% | Upgrade
|
| Profit Margin | 4.02% | 11.73% | 12.60% | 16.98% | 10.08% | 8.65% | Upgrade
|
| Free Cash Flow Margin | -0.50% | 14.26% | 7.26% | -13.14% | -39.89% | -79.35% | Upgrade
|
| EBITDA | 45.12 | 80.28 | 68.43 | 44.62 | 36.02 | 26.94 | Upgrade
|
| EBITDA Margin | 13.99% | 23.17% | 21.96% | 18.31% | 17.92% | 14.64% | Upgrade
|
| D&A For EBITDA | 23.91 | 22.92 | 21.38 | 12.54 | 10.19 | 9.24 | Upgrade
|
| EBIT | 21.21 | 57.36 | 47.05 | 32.09 | 25.84 | 17.7 | Upgrade
|
| EBIT Margin | 6.57% | 16.56% | 15.10% | 13.16% | 12.85% | 9.62% | Upgrade
|
| Effective Tax Rate | 22.61% | 22.75% | 3.99% | - | 26.81% | 27.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.